According to The Kobeissi Letter, UnitedHealth Group's stock ($UNH) experienced a significant decline of 20% since Monday following the DOJ's announcement of a civil fraud probe into the company's Medicare billing practices. The stock had already fallen 9% earlier in the week on minimal news, raising questions about potential prior knowledge of the investigation. Investors should closely monitor the situation as further developments could impact trading strategies and market sentiment regarding $UNH.

According to The Kobeissi Letter, UnitedHealth Group's stock, $UNH, dropped by 12% following the announcement of a civil fraud probe by the US Department of Justice into the company's Medicare billing practices. This significant price movement is critical for traders monitoring the healthcare sector, as legal challenges could further impact UnitedHealth's stock performance and market valuation.